Skip to main content

Table 3 Influencing factors by i-PARIHS domain

From: Using the Matrixed Multiple Case Study approach to identify factors affecting the uptake of IPV screening programs following the use of implementation facilitation

i-PARIHS domains

Factors with enabling influence across all sites

Factors deemed important to implementation success

Factors differentiating sites with high/medium versus low implementation success

Facilitation (F)

F1. Internal facilitator or other site staff are available to meet and communicate regularly

F3. External facilitator is available and willing to meet and communicate regularly

 

F2. Internal facilitator or IPVAP Coordinator organizes/conducts staff training for IPV screening

F4. External facilitator is perceived as knowledgeable about IPV screening practices and available resources

 

Innovation (I)

 

I1. IPV screening is seen as duplicative with other established clinical reminders

I2. IPV screener points toward appropriate follow-up if someone screens positive

Recipients (R)

R1. IPVAP Coordinator is available and actively engaged in supporting IPV screening day-to-day implementation activities at the main hospital and/or connected Community-Based Outpatient Clinics

R2. Primary care team is available to screen for IPV during patient visits

 

R3. Frontline staff have the expertise and available resources to conduct and follow-up IPV screening as intended (e.g., trained primary care social workers)

 

R4. At least one frontline primary care staff person is supportive of IPV screening in the identified clinics

 

Context (C)

 

C1. Site has engaged IT team or infrastructure in place to support IPV screening prior to initiation of IF activities

 
 

C2. Site-level primary Care, women’s health, social work, and/or medical center leadership is supportive of IPV screening in identified clinic(s), e.g., by providing staff support and/or protected time for IPV screening activities

 
 

C3. Competing priorities created barriers to prioritizing IPV screening implementation (e.g., COVID-19, other initiatives)

 
 

C4. Regional and/or national leadership is supportive of IPV screening

 
 

C5. Access to community resources for additional support for Veterans